柏勒罗丰治疗 (BLPH)公告，柏勒罗丰治疗新闻

公告

0.00%

全部
财务报告
内部人交易

SC 13G/A Bellerophon Therapeutics, Inc. (0001600132) (Subject)
2021-02-12 17:27
8-K Bellerophon Therapeutics, Inc. (0001600132) (Filer)
2021-01-11 08:01
Form8-K Bellerophon Therapeutics, Inc.
2020-12-01 08:31
Form8-K Bellerophon Therapeutics, Inc.
2020-11-23 08:33
Form10-Q Bellerophon Therapeutics, Inc.
2020-11-05 08:29
Form8-K Bellerophon Therapeutics, Inc.
2020-11-05 08:30
Form4 Bellerophon Therapeutics, Inc.
2020-09-14 16:03
Form4 Bellerophon Therapeutics, Inc.
2020-09-14 16:03
Form4 Bellerophon Therapeutics, Inc.
2020-09-14 16:04
Form4 Bellerophon Therapeutics, Inc.
2020-09-14 16:04
Form4 Bellerophon Therapeutics, Inc.
2020-09-14 16:02
Form4 Bellerophon Therapeutics, Inc.
2020-09-14 16:03
Form4 Bellerophon Therapeutics, Inc.
2020-09-14 16:02
Form4 Bellerophon Therapeutics, Inc.
2020-09-14 16:02
Form4 Bellerophon Therapeutics, Inc.
2020-09-14 08:31
Form3 Bellerophon Therapeutics, Inc.
2020-09-11 16:10
Form10-Q Bellerophon Therapeutics, Inc.
2020-08-05 08:26
Form8-K Bellerophon Therapeutics, Inc.
2020-08-05 08:31
424B5 Bellerophon Therapeutics, Inc. (0001600132) (Filer)
2020-07-17 17:01
8-K Bellerophon Therapeutics, Inc. (0001600132) (Filer)
2020-07-17 17:01
8-K Bellerophon Therapeutics, Inc. (0001600132) (Filer)
2020-07-13 08:33
EFFECT Bellerophon Therapeutics, Inc. (0001600132) (Filer)
2020-07-06 00:15
CORRESP Bellerophon Therapeutics, Inc.
2020-07-01 16:03
UPLOAD Bellerophon Therapeutics, Inc.
2020-07-01 08:12
CORRESP Bellerophon Therapeutics, Inc.
2020-07-01 21:30
S-3 Bellerophon Therapeutics, Inc. (0001600132) (Filer)
2020-06-26 16:07
8-K Bellerophon Therapeutics, Inc. (0001600132) (Filer)
2020-06-12 16:06
4 Bellerophon Therapeutics, Inc. (0001600132) (Issuer)
2020-06-09 16:01
SC 13D Bellerophon Therapeutics, Inc. (0001600132) (Subject)
2020-05-22 07:38
4 Bellerophon Therapeutics, Inc. (0001600132) (Issuer)
2020-05-22 07:25
SC 13D/A Bellerophon Therapeutics, Inc. (0001600132) (Subject)
2020-05-22 06:46
424B5 Bellerophon Therapeutics, Inc.
2020-05-20 16:02
424B5 Bellerophon Therapeutics, Inc.
2020-05-20 16:03
8-K Bellerophon Therapeutics, Inc.
2020-05-20 16:04
424B5 Bellerophon Therapeutics, Inc. (0001600132) (Filer)
2020-05-18 16:02
8-K Bellerophon Therapeutics, Inc. (0001600132) (Filer)
2020-05-11 16:03
10-Q Bellerophon Therapeutics, Inc. (0001600132) (Filer)
2020-05-11 16:01
8-K Bellerophon Therapeutics, Inc. (0001600132) (Filer)
2020-05-11 08:29
DEFA14A Bellerophon Therapeutics, Inc. (0001600132) (Filer)
2020-04-27 16:31
4 Bellerophon Therapeutics, Inc. (0001600132) (Issuer)
2020-04-20 10:47
8-K Bellerophon Therapeutics, Inc. (0001600132) (Filer)
2020-04-08 08:31
8-K Bellerophon Therapeutics, Inc. (0001600132) (Filer)
2020-04-06 08:32
10-K Bellerophon Therapeutics, Inc. (0001600132) (Filer)
2020-04-06 08:27
8-K Bellerophon Therapeutics, Inc. (0001600132) (Filer)
2020-03-31 13:28
424B5 Bellerophon Therapeutics, Inc. (0001600132) (Filer)
2020-03-31 07:03
8-K Bellerophon Therapeutics, Inc.
2020-03-30 16:09
SC 13G Bellerophon Therapeutics, Inc.
2020-03-30 10:49
8-K Bellerophon Therapeutics, Inc.
2020-03-30 08:01
8-K Bellerophon Therapeutics, Inc. (0001600132) (Filer)
2020-03-20 08:33
8-K Bellerophon Therapeutics, Inc. (0001600132) (Filer)
2020-03-10 08:33

微牛提供最新的柏勒罗丰治疗(BLPH)股票新闻与公司公告，以帮助你进行明智的交易与投资决策。

BLPH 简况

Bellerophon Therapeutics, Inc.是一家临床阶段的治疗公司。该公司致力于开发满足心肺疾病医疗需求的药物和设备。该公司致力于开发治疗肺动脉高压（PH）的一氧化氮疗法，该疗法使用INOpulse输血系统，其中肺动脉高压（PAH）为主要指标。INOpulse设备具有在呼吸开始时定时产生短暂靶向脉冲一氧化氮的机制，以将一氧化氮递送到肺泡，这一机制最小化治疗所需药物量。该公司的另一个项目BCM是一种致力于预防伴随ST段抬高型心肌梗死（STEMI）的充血性心力衰竭的医疗设备，STEMI是一种严重的心脏病发作。该公司的BCM正处于临床试验PRESERVATION第一阶段。